Article defending private-equity involvement in autism services retracted
Nearly two-thirds of the article’s references appear to not exist.
Nearly two-thirds of the article’s references appear to not exist.
Going forward, the American College of Neuropsychopharmacology plans to gather at “non-discriminatory sites,” following the passage of Florida laws targeting LGBTQ+ people and reproductive rights.
A dozen papers have been retracted so far, and six more are planned.
The paper was published in a journal that shut down after being overrun by paper mills.
The New York State Psychiatric Institute in New York City is undergoing an audit and a change in leadership following a suicide that occurred during one of its clinical trials.
A total of 17 studies have already been retracted or are slated for retraction over issues with participant consent.
The University of Maryland found the papers included some data without participant consent.
The journal’s decision comes two years after Spectrum covered backlash from researchers over the study.
The paper marks the second retraction for one of the co-authors.
The papers were flagged by a method that has now been called into question.